September 2017 – CAR-T Cell Therapy Resource Center

VIDEO: Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors

Published on August 31, 2011 Researchers at Penn’s Abramson Cancer Center have molecularly engineered T-cells from patients with chronic lymphocytic leukemia and achieved an exceptional, unprecedented antitumor response. In the …

FDA

FDA Approves First Gene Therapy in the United States

- by Editor - Leave a Comment

August 30, 2017 (HealthDay News) Kymriah approved for patients up to 25 years of age with refractory or relapsed B-cell precursor ALL The U.S. Food and Drug Administration on Wednesday …